SAKURAGI TSUTOMU , NISHIKIDO MASAHARU , KUBOTA SHIGEHIRO , KUSABA YASUYUKI , KANETAKE HIROSHI , SHINDO KAZUHIKO , SAITO YUTAKA

T-2588 was orally administered to 11 cases with complicated urinary tract infection at the dose of 300mg per day. Seven cases were treated for 5 days and 4 cases for 7 days. The following results were …

CHEMOTHERAPY 34(Supplement2), 825-830, 1986

J-STAGE